CXCL10 and metabolic dysfunction-associated steatotic liver disease: Plasma IP-10 exhibited a high accuracy in discriminating NAFLD from control subjects, with an area under the ROC curve (AUROC) of 0.80 (95% CI 0.72–0.88, P < 0.0001) (Fig. 6A).